White matter hyperintensities and their impact in brain structure and function in alzheimer's disease and behavioral variant frontotemporal dementia across Latin America and the United States: a cross-sectional study
Alzheimers Res Ther. 2025 Aug 12;17(1):188. doi: 10.1186/s13195-025-01832-5.
ABSTRACT
BACKGROUND: White matter hyperintensities (WMHs) are a core manifestation of normal and pathological aging and are potentially linked to geographical differences in social and physical exposomes. Previous studies have not examined the impact of WMHs burden on neurodegeneration and cognition in healthy controls (HCs) and patients with Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD) across geographic regions. This study addressed this gap by assessing the impact of WMHs burden on participants with and without dementia from Latin America (LA) and the United States (US).
METHODS: The study comprised 994 participants, including HCs (n = 402), AD (n = 359), and bvFTD subjects (n = 233) from LA and the US. WMHs and their association with grey matter (GM) atrophy, assessed through GM volume and cortical thickness, were evaluated and compared among groups (HCs, AD, and bvFTD) in LA and the US using a voxel-wise brain imaging approach (p < 0.05 family-wise error-corrected for multiple comparisons, minimum cluster size = 50 voxels). Multiple regressions analysis were employed to examine geographic differences in WMHs burden, WMHs-GM associations, and the effect of WMHs on cognitive performance, as assessed by the Mini-Mental State examination.
RESULTS: In the LA cohort only, higher WMHs load was associated with greater GM atrophy across all groups (HCs, AD, bvFTD), with a specific neurodegenerative pattern involving orbitofrontal, cingulate, and temporal areas. HCs from LA showed a greater WMHs load than their US counterparts, and this effect was dependent on GM atrophy. Finally, WMHs burden negatively impacted cognitive performance in dementia subjects, with a greater effect observed in bvFTD subjects from the US.
CONCLUSION: WMHs have a more pronounced impact on neurodegeneration across the LA cohort, with a worse impact on HCs, which also show higher WMHs burden than their US counterparts. This could increase the risk of developing dementia. Moreover, WMHs burden differentially impacts cognition, with a greater negative effect observed in bvFTD subjects from the US. These findings highlight geographic variations in WMHs-related conditions, offering valuable insights for tailored future research.
PMID:40797280 | DOI:10.1186/s13195-025-01832-5
Authors
Sandra Báez, PhD, MS
Neuroscientist, Neuropsychologist
Joaquín Migeot, MSc, PhD
Neuroscientist
Sol Fittipaldi, PhD
Neuroscientist
Agustina Legaz, PhD
Neuroscientist
Maria Eugenia Godoy, MSc
Project Manager
Sebastian Moguilner, PhD
Neuroscientist
Josefina Cruzat, PhD, MS
Neuroscientist
Carlos Coronel, PhD
Neuroscientist
Hernando Santamaría-García, MD, MSc, PhD
Psychiatrist and Researcher
Pablo Alexander Reyes Gavilan, PhD
Neuropsychologist
Andrea Slachevsky, MD, PhD
Stefanie Piña Escudero, MD
Geriatrician
Elisa França Resende, MD, PhD
Neurologist
Kate Possin, PhD
Professor of Neurology
Maira Okada de Oliveira, PhD
Neuropsychologist
Brian Lawlor, MD, FRCPI, FRCPsych, MRIA
Founding Director, Trinity College Dublin
Jennifer Yokoyama, PhD
Associate Professor of Neurology
Bruce Miller, MD
Founding Director, University of California, San Francisco
Adolfo M. García, PhD
Neuroscientist
Agustín Ibáñez, PhD
Neuroscientist